{"id":"W3170117047","doi":"10.1200/jco.2021.39.15_suppl.e13020","title":"First-line treatment with a cyclin-dependent kinase 4/6 inhibitor combined with an aromatase inhibitor for hormone receptor-positive, human epidermal growth factor receptor-2 negative metastatic breast cancer: Population-based outcomes for patients treated in Alberta, Canada.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Palbociclib; Medicine; Internal medicine; Metastatic breast cancer; Aromatase inhibitor; Oncology; Population; Breast cancer; Progression-free survival; Proportional hazards model; Cancer; Hazard ratio; Gastroenterology; Aromatase; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003154814,0.0002900289,0.0004380552,0.0006257974,0.0008417865,0.0008000424,0.0007112087,0.0003440634,0.001499486],"category_scores_gemma":[0.0008835854,0.0002003953,0.0006828048,0.002054331,0.0004672053,0.0002873123,0.0004983356,0.0007850653,0.0001845006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01406306,"about_ca_system_score_gemma":0.01056807,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7773185,"about_ca_topic_score_gemma":0.8983608,"domain_scores_codex":[0.9995448,0.00001829027,0.00002152878,0.00007111041,0.0001795654,0.0001646153],"domain_scores_gemma":[0.9991953,0.00003986709,0.000328507,0.00002325846,0.0001452509,0.0002679483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007118973,0.00009493159,0.9885646,0.00006653987,0.0001422408,0.000200466,0.0001357193,0.0003669447,0.000479664,0.00004483344,0.001242808,0.007949427],"study_design_scores_gemma":[0.00006386748,0.0002872123,0.9973,0.00003018895,0.00009945833,0.0003376525,0.0003005338,0.0004038821,0.0001129371,0.0000285814,0.001025023,0.00001069112],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929686,0.001646822,0.00009959282,0.0001802558,0.00001378548,0.00007525351,0.003346773,0.00001592862,0.00165307],"genre_scores_gemma":[0.9956672,0.000672065,0.0001106035,0.0001036581,0.00001515051,0.00001612004,0.002731889,0.000004051957,0.000679164],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2226815,"threshold_uncertainty_score":0.4479858,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03958041499443192,"score_gpt":0.37131618201223,"score_spread":0.3317357670177981,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}